Workflow
TALARIS THERAPEU(TALS) - 2024 Q2 - Quarterly Report
TALSTALARIS THERAPEU(TALS)2024-08-08 12:46

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q _____________________________ (Mark One) TOURMALINE BIO, INC. (Exact name of Registrant as specified in its Charter) ___________________________________________________________ Delaware 83-2377352 (State or other jurisdiction of incorporation or organization) 27 West 24th Street, Suite 702 New York, NY 10010 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code ...